U.S. Markets open in 6 hrs 39 mins

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
1.2400-0.0500 (-3.88%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.28
52-Week Change 3-73.13%
S&P500 52-Week Change 3N/A
52 Week High 35.9000
52 Week Low 30.3900
50-Day Moving Average 30.8418
200-Day Moving Average 30.8301

Share Statistics

Avg Vol (3 month) 324.26M
Avg Vol (10 day) 323.08M
Shares Outstanding 5125.74M
Float 52.29M
% Held by Insiders 10.05%
% Held by Institutions 17.00%
Shares Short (Jul 14, 2020) 41.44M
Short Ratio (Jul 14, 2020) 40.09
Short % of Float (Jul 14, 2020) 41.15%
Short % of Shares Outstanding (Jul 14, 2020) 41.15%
Shares Short (prior month Jun 14, 2020) 4751.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Oct 31, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-69.11%
Return on Equity (ttm)-120.91%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -29.8M
Net Income Avi to Common (ttm)-33.84M
Diluted EPS (ttm)-4.5160
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.66M
Total Cash Per Share (mrq)0.59
Total Debt (mrq)281k
Total Debt/Equity (mrq)0.90
Current Ratio (mrq)12.56
Book Value Per Share (mrq)0.63

Cash Flow Statement

Operating Cash Flow (ttm)-27.37M
Levered Free Cash Flow (ttm)-16.34M